Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Other Accumulated Expenses (2018 - 2025)

Historic Other Accumulated Expenses for ImmunoTech (AIM) over the last 6 years, with Q3 2025 value amounting to $75000.0.

  • ImmunoTech's Other Accumulated Expenses rose 10270.27% to $75000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $75000.0, marking a year-over-year increase of 10270.27%. This contributed to the annual value of $33000.0 for FY2024, which is 833.33% down from last year.
  • According to the latest figures from Q3 2025, ImmunoTech's Other Accumulated Expenses is $75000.0, which was up 10270.27% from $62000.0 recorded in Q2 2025.
  • In the past 5 years, ImmunoTech's Other Accumulated Expenses ranged from a high of $106000.0 in Q3 2023 and a low of $8000.0 during Q2 2024
  • Over the past 3 years, ImmunoTech's median Other Accumulated Expenses value was $45500.0 (recorded in 2024), while the average stood at $50400.0.
  • As far as peak fluctuations go, ImmunoTech's Other Accumulated Expenses plummeted by 9024.39% in 2024, and later skyrocketed by 67500.0% in 2025.
  • ImmunoTech's Other Accumulated Expenses (Quarter) stood at $36000.0 in 2023, then fell by 8.33% to $33000.0 in 2024, then soared by 127.27% to $75000.0 in 2025.
  • Its Other Accumulated Expenses was $75000.0 in Q3 2025, compared to $62000.0 in Q2 2025 and $54000.0 in Q1 2025.